Cargando…
AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series
One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID‐19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID‐19 vaccine, indicating a relationship between th...
Autores principales: | Siddig, Amira, Abbasher Hussien Mohamed Ahmed, Khabab, Hassan Haroun, Mazin S., M. Abdallah, Abdallah, Malekaldar, Mohamed, Abbasher, Al Hussien, Abbasher, Mohammed, Abbasher, Abubaker Alsedig, Hussien, Abbasher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272208/ https://www.ncbi.nlm.nih.gov/pubmed/35846901 http://dx.doi.org/10.1002/ccr3.6017 |
Ejemplares similares
-
COVID‐19 and cognitive impairment: A cross‐sectional clinic‐based study
por: Siddig, Amira, et al.
Publicado: (2022) -
Etiological associations of cerebral venous sinus thrombosis among adult sudanese patients: a multicenter cross-sectional study
por: Malekaldar, Mohamed, et al.
Publicado: (2023) -
Neurological manifestations of mycetoma: a cross-sectional community-based study
por: Ali, Elkhansa A., et al.
Publicado: (2023) -
COVID-19 and stroke: Case report
por: Tofaha Alhusseini, Radi, et al.
Publicado: (2021) -
Clinical profile and risk factors of cerebral venous sinus thrombosis (CVST) in Sudan: A multicenter cross-sectional study
por: Ibrahim, Etedal Ahmed A., et al.
Publicado: (2022)